Advertisement

Picture Berlin Partner Top News EIC Accelerator Noah Labs MyoPax 650x100px
Document › Details

Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA.

Organisations Organisation Amgen Inc. (Nasdaq: AMGN)
  Group Amgen (Group)
  Organisation 2 Horizon Therapeutics plc (Nasdaq: HZNP)
  Group Horizon Therapeutics (Group)
Products Product Tepezza™
  Product 2 investment banking
Index term Index term Horizon Therapeutics–Amgen: investment, 202212– acquisition recommended cash offer $27.8b for all outstanding shares at $116.5/share
Persons Person Walbert, Timothy P. (Tim) (Horizon Pharma 201003– CEO before IDM Pharma CEO before NeoPharm + Abbott)
  Person 2 Bradway, Robert A. (Amgen 201403 CEO before CFO before Morgan Stanley)
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for Amgen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x300px




» top